INTRODUCTION {#S1}
============

Fibrosis is an evolutionary body strategy to rapidly close and repair wounds ([@R5]; [@R18]). In the lung, fibrosis occurs when there is an ongoing epithelial injury ([@R39]; [@R55]). Fibrosis in patients with idiopathic pulmonary fibrosis (IPF) results in persistent and relentlessly progressive lung scarring ([@R54]; [@R56]; [@R58]), which leads to \~40,000 deaths every year in the US. The major effector cells in this process are the mesenchymal cells (MCs) ([@R36]). MCs are believed to consist of multiple subtypes that are being intensively investigated ([@R30]; [@R33]; [@R63]; [@R66]), but it is unclear how many mesenchymal subtypes exist and how they differ from or are related to one another, and their cellular biology is poorly defined. Thus, these limitations hinder severely our ability to understand the cellular events and the molecular signaling pathways in the distinct subsets of fibroblasts in fibrogenesis, and to develop precise cellular models and animal models of lung fibrosis.

Pulmonary MCs are suggested to be extremely heterogeneous in IPF ([@R25]) and in mouse models ([@R49]), suggesting that they could be derived from different cell types, represent different stages of activation, or may be influenced by the surrounding milieu. MC clones separated by Thy1 seem to have different morphology, growth characteristics, display of antigens, and collagen and fibronectin production ([@R11]). Subsets of MCs distinguished by Pdgfrα expression were reported to express different levels of α-smooth muscle actin (α SMA) ([@R27]). The regional airway MCs were suspected to be distinct from the distal lung MCs in terms of morphology, collagen and α SMA expression, and proliferation ([@R29]). Using genetic lineage tools to characterize lung MCs has provided some insights into subtypes. *Fgf10* lineage MCs ([@R14]); pericytes trace labeled with *NG2*, *FoxJ1*, or *Foxd1* ([@R22]; [@R49]); or *Plin2*-traced lipofibroblasts ([@R15]) were suggested to contribute to α SMA-expressing myofibroblasts and various MC subsets. We recently reported that *Tbx4*-lineage cells compose a large fibroblast population within the lung, including α SMA^+^, Col1α 1^+^, NG2^+^, vimentin^+^, desmin^+^, Pdgfrα ^+^, and Pdgfrβ^+^ fibroblasts ([@R63]). These data suggest the existence of cellular subpopulations of fibroblasts, which vary with anatomical locations, gene expression, and cell surface markers. However, the enumeration of cell types and their definition can be controversial based on restricted markers available to identify, isolate, and manipulate. Biased morphology, physical properties, localization, molecular markers, functions, and developmental origins would alter the assignment of diversification and cellular differentiation for mesenchymal subtypes. Therefore, a systematic map of evolutionary pulmonary mesenchymal heterogeneity in both steady-state and pathological conditions remains unexposed.

To overcome these challenges, efforts have been made to systematically classify lung MCs. The Lung Gene Expression in Single-Cell (LungGENS) program separated MCs into proliferative mesenchymal progenitor, myofibroblast/smooth muscle, pericyte, intermediate fibroblast 1 and 2 and matrix fibroblast on embryonic (E) 16.5, and FB (LipoFibroblast/Matrix Fibroblast) and myofibroblast/smooth muscle on E18.5 and postnatal mouse lungs by single-cell RNA sequencing (scRNA-seq) analysis using the Fluidigm C1 platform ([@R13]). However, the numbers of fibroblasts included in the studies were small because of the limitation of the C1 platform. To conquer some of these obstacles, we used an unbiased approach: Drop-Seq single-cell RNA-seq (scRNA-seq; 10x Genomics) with much larger numbers of MCs to better assess the diversity of pulmonary MCs, leading to the identification of new subtypes of fibroblasts, and refine their existing classifications. We further assessed the signature genes, enriched extracellular and soluble protein coded genes, key transcription factors, and, notably, expressed long non-coding RNAs (lncRNAs) for each subtype. In addition, pseudo-time analysis was used to delineate the mesenchymal cellular paths of differentiation. Overall, our analysis provides a comprehensive map of the subtypes of the stromal taxonomy in steady-state in adult mice and fibrotic lung.

RESULTS {#S2}
=======

Classification of Mesenchymal Heterogeneity by scRNA-Seq in Normal and Fibrotic Mouse Lung Tissues {#S3}
--------------------------------------------------------------------------------------------------

We set out to comprehensively identify and define subpopulations of the MCs between normal and fibrotic lung tissues. We treated α*SMA*-*GFP;Tbx4-Cre;Rosa26-tdTomato* mice with bleo-mycin and harvested the lungs after injury ([Figure 1A](#F1){ref-type="fig"}). We obtained enriched MCs by fluorescence-activated cell sorting (FACS) Epcam^−^CD31^−^45^−^ cells from single lung homogenates and performed scRNA-seq using the 10x Genomics Chromium platform ([Figure 1B](#F1){ref-type="fig"}). We profiled 1,943 cells from normal mouse lung and 3,386 cells from fibrotic α*SMA*-*GFP;Tbx4-Cre;Rosa26-tdTomato* mouse lung. We visualized the cells in two dimensions according to their expression profiles by t-distributed stochastic neighborhood embedding (t-SNE) projections. Six subtypes as MCs in normal lung and seven subtypes in fibrotic lung were well segregated ([Figures 1C and 1D](#F1){ref-type="fig"}). Endothelial cells also were included in the analysis. The other cell types such as epithelial cells contaminated during flow sorting were minimal and easily identifiable, and were eliminated from further analysis. We tentatively classified mesenchymal populations based on their preferential or distinctive marker expression and relations to known cell types. The compositions of these clusters were myofibroblasts, 16% in normal and 11% in fibrotic lung; *Col13a1* matrix fibroblasts, 13% in normal and 24% in fibrotic lung; *Col14a1* matrix fibroblasts, 17% in normal and 26% in fibrotic lung; lipofibroblasts, 27% in normal and 25% in fibrotic lung; mesenchymal progenitors, 5% in normal and 2% in fibrotic lung; mesothelial cells, 2% in normal and 2% in fibrotic lung; and endothelial cells, 20% in normal and 9% in fibrotic lung. A new *Pdgfrb* high (hi) subpopulation appeared only in the fibrotic lung, which comprised \~1% of all MCs ([Figures 1C and 1D](#F1){ref-type="fig"}). Heatmaps of normalized MC profiles revealed normalized expression of the top variable genes in each MC subtype ([Figures 1E and 1F](#F1){ref-type="fig"}). We further analyzed tdTomato (tdT)^+^GFP^+^ cells from α*SMA*-*GFP;Tbx4-Cre;Rosa26-tdTomato* mice to confirm the MC subtypes ([Figures 1G and 1H](#F1){ref-type="fig"}). As expected, these subtypes and the patterns of composition were consistently reproduced in the analyses of 614 MCs in normal and 2,835 MCs in fibrotic tdT^+^GFP^+^ cells. Together, these unbiased analyses delineated the fibroblast heterogeneity in the adult mouse lungs and further identified mesenchymal subpopulation changes during lung fibrogenesis.

Single-Cell Profiling of Myofibroblasts {#S4}
---------------------------------------

Using known marker genes for myofibroblasts, including *Acta2* ([@R20]), *Myh11* ([@R21]), and *Tagln* ([@R13]; [@R48]) ([Figures 2A--2C](#F2){ref-type="fig"}), a myofibroblast cluster was readily identified. Top 10 genes were highly and specifically expressed in myofibroblasts and absent or much less expressed in other MC subtypes, providing a series of novel markers that can distinguish myofibroblasts from other fibroblasts under both normal and fibrotic conditions ([Figures 2D and 2E](#F2){ref-type="fig"}). The expression levels of the top highly expressed lncRNAs in myofibroblasts; the top 36 most abundant expressed genes, including extracellular and plasma membrane coding genes; and the most abundant transcription factors were analyzed and compared between normal and fibrotic myofibroblast subtypes ([Figures 2F--2I](#F2){ref-type="fig"}). Among the newly identified putative myofibroblast markers, several are of particular interest. *Hhip*, which has been reported to be involved in maintaining normal lung function and alveolar structures ([@R31]), is the highest specifically expressing gene in the myofibroblast subtype. *Aspn* has been reported to be significantly expressed in IPF lung samples ([@R34]). *Mustn1*, which has been reported to be expressed in skeletal muscle, is believed to be an essential regulator of myogenic differentiation and myofusion ([@R40]). All three of these were better markers of myofibroblasts than was *Acta2*, which is consistent with the results of a recent report ([@R52]). Junb is a component of transcription complex AP1 ([@R1]). AP1, which has been shown to play a key role in fibrotic diseases, and *Scx*, a transcription factor reported to be a critical regulator of the cardiac fibroblast/myofibroblast phenotype ([@R2]), are showing up as the most distinctive transcription factors of myofibroblast subtypes in both normal and fibrotic conditions. These analyses identified novel markers and transcription networks in the myofibroblast subtype.

Transcriptional Signature Associated With Col13a1 Matrix Fibroblasts {#S5}
--------------------------------------------------------------------

Matrix fibroblasts express signature genes associated with extracellular matrix and cell adhesion. We found that these *Col1a1* highly expressing matrix fibroblasts clustered together ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). *Col13a1* and *Col14a1* are highly discriminative markers within the matrix fibroblast clusters, segregating them into two distinct subtypes. We refer to these subsets henceforth as *Col13a1* and *Col14a1* matrix fibroblasts ([Figures 3A and 3B](#F3){ref-type="fig"}). Previously reported matrix fibroblast markers are dominantly expressed in both *Col13a1* and *Col14a1* matrix fibro-blasts ([Figure 3C](#F3){ref-type="fig"}). *Col13a1* matrix fibroblasts were accurately delineated by *Itga8*, *Cxcl14*, *Npnt*, and other top signature genes in both normal and fibrotic lung ([Figures 3D and 3E](#F3){ref-type="fig"}). Most of the highly expressed lncRNAs were analyzed and ordered by the range of their expression ([Figure 3F](#F3){ref-type="fig"}), with *Neat1* being the most abundantly expressed lncRNA. The top 50 significantly expressed genes were listed with discrimination of the extracellular and plasma membrane expressing genes, and their expression levels were depicted as heatmaps ([Figure 3G](#F3){ref-type="fig"}). Chemokine *Cxcl14* is the most distinct extracellular expressed gene in *Col13a1* matrix fibroblasts. Plasma membrane associated gene *Itga8* can uniquely delineate *Col13a1* matrix fibroblasts. Both *Cxcl14* and *Igta8* are increased in fibrotic *Col13a1* matrix fibroblasts. Transcription factor *Tcf21* strongly marked the *Col13a1* matrix fibroblasts, with more abundant expression at the fibrotic phase ([Figure 3H](#F3){ref-type="fig"}). Tcf21 has been used to lineage trace resident cardiac fibroblasts during pathologic remodeling ([@R62]). Other top transcription factors include *Lbh*, *Nr2f2*, *Tbx2*, and *Meox2* ([Figure 3I](#F3){ref-type="fig"}).

Delineation of Col14a1 Matrix Fibroblasts {#S6}
-----------------------------------------

Unlike *Col13a1* matrix fibroblasts, *Col14a1* matrix fibroblasts distinguish themselves by harboring a unique set of significant genes, including *Pi16*, *Mmp3*, *Cygb*, and *Rtp4* ([Figures 4A--4D](#F4){ref-type="fig"}). *Meg3* and *Snhg18* are the most abundant lncRNAs expressed in the *Col14a1* matrix fibroblasts. The percentage of the cells expressing *Meg3* in *Col14a1* matrix fibroblasts and the average transcript count of *Meg3* are decreased, whereas the percentage of cells expressing *Snhg18* is increased in fibrotic *Col14a1* matrix fibroblasts ([Figure 4E](#F4){ref-type="fig"}). *Meg3* lncRNA has been suggested to be expressed in tissue fibrosis ([@R19]; [@R45]). The top discriminative extracellular expressing genes are *Pi16* and *Mmp3* for *Col14a1* matrix fibroblasts, but with low transcript levels. *Clec3b* and *Dcn* are more significantly expressed, but with less distinction ([Figure 4F](#F4){ref-type="fig"}). For transcription factors, mesoderm homeobox gene *Prrx1* is the top factor in *Col14a1* matrix fibroblasts, with *Aebp1* and *Lbh* highly expressed as well ([Figures 4G and 4H](#F4){ref-type="fig"}).

Elucidation of a Lipofibroblast Gene Signature {#S7}
----------------------------------------------

Lipofibroblasts are lipid-containing interstitial fibroblasts ([@R43]; [@R57]). The previously suggested markers for lipofibroblasts include *Adrp* ([@R15]; [@R51]), *Pparg* ([@R59]), *Fabp1*, *Fabp 4*, *Fabp5* ([@R9], [@R10]; [@R38]), and *Lpl* ([@R23]). We found that these *Adrp* and *Pparg* highly expressing MCs were clustered together to form a distinct subpopulation, and at the same time, this cluster also expresses considerable levels of *Fabp1,4,5*, *Lpl*, and *Lipa*. Therefore, we referred to this cluster as lipofibroblasts ([Figures 5A--5C](#F5){ref-type="fig"}). We further examined the cluster and found that this subtype expresses immune function-related genes along with mesenchymal genes. The top signature genes include *Ear1* and *Ear2*, *Mrc1*, *Ccl6*, *Plet1*, *Abcg1*, and *Krt79* ([Figures 5D and 5E](#F5){ref-type="fig"}). Furthermore, the cluster also expresses common fibro-blast genes such as *Pdgfra*, *Vim*, *Col4a1*, and *Fn1* ([Figure S2A](#SD1){ref-type="supplementary-material"}). Therefore, the expression patterns of the lipofibroblast subtype possessed a lipid synthesis and transport gene signature, as well as a mesenchymal feature. The top expressing lncRNA is AI504432, which is located on the opposite strand of the *Kcna3* gene, with expression level and percentage decreased in fibrotic lipofibroblasts ([Figure 5F](#F5){ref-type="fig"}). We also compared the expression levels for the top 50 highest expressed genes, including extracellular and plasma membrane genes, between normal and fibrotic lipofibroblasts ([Figure 5G](#F5){ref-type="fig"}). It is interesting that M2 macrophage-like signature genes (*Chil3*, *Mrc1*, *IL18*, and *CD9*) ([@R32]), together with mesenchymal genes (*Mlc1*, *Plek*, *CD44*, *Ptpn12*, *and Slpi*), are expressed in the lipofibroblast subtype ([Figures S2B](#SD1){ref-type="supplementary-material"} and [5G](#F5){ref-type="fig"}). The most distinctive transcription factor for the lipofibroblast is *Nfib*, and its expression level is the lowest within the MC subtypes ([Figure 5H](#F5){ref-type="fig"}). Other top expressed transcription factors include *Runx1*, *Baz1a*, *Cebpa*, and *Hcls1* ([Figure 5I](#F5){ref-type="fig"}).

Identification of a Subgroup of Potential Mesenchymal Progenitors {#S8}
-----------------------------------------------------------------

Mesenchymal progenitors are characterized by their self-renewal capacity and a signature enriched with proliferative genes. The term ''mesenchymal progenitor'' was adapted from the nomenclature by the LungGENS project ''Proliferative Mesenchymal Progenitors'' ([@R13]). We observed a cluster of cells expressing high levels of *Top2a* and *Mki67*. We henceforth hypothesized that these cells could act as mesenchymal progenitors ([Figures S3A--S3C](#SD1){ref-type="supplementary-material"}). We further characterized the predominantly expressed genes within this cluster and found that *Hist1h2ap*, *Ube2c*, *H2afx*, *Cks2*, *Hmgb2*, and *Ccnb2* were distinct markers. These genes are related to cell cycle, cell proliferation, DNA metabolism, nuclear division, and mitotic cell cycle ([Figures S3D and S3E](#SD1){ref-type="supplementary-material"}). They are variably expressed during normal and fibrotic status but typically present in the mesenchymal progenitor cluster. Top expressed lncRNAs in this cluster were *Malat1* and *Lockd* ([Figure S3F](#SD1){ref-type="supplementary-material"}). The most significant extra-cellular expressed gene is *Hmgb2*. The distinct plasma membrane genes are *S100a8* and *Cd52*. Given the insufficiency of *S100a8* surface expression, CD52 would be a better cell surface marker for the mesenchymal progenitors ([Figure S3G](#SD1){ref-type="supplementary-material"}). In addition, *Hmgb2* is the most highly expressed transcription factor in the mesenchymal progenitor subtype ([Figure S3H](#SD1){ref-type="supplementary-material"}), together with *Ezh2*, *Uhrf1*, *Mcm6*, *Hmgb3*, and *Mcm5* as the specifically expressed transcription factors in mesenchymal progenitors ([Figure S3I](#SD1){ref-type="supplementary-material"}). The LungGENS project identified 453 signature genes for the proliferative mesenchymal progenitors (PMPs). These 453 genes showed up in our differentiated gene list for mesenchymal progenitors (both D0 and D21) ([Table S1](#SD2){ref-type="supplementary-material"}), with various p value ranks. Within the 23 genes that were upregulated and log2 fold change \>2 in the D0 mesenchymal progenitors, 13 genes were identical as PMP signature genes. Forty-six genes are upregulated and log2 fold change \>2 in the D21 mesenchymal progenitors, and 23 genes are the same as PMP signature genes ([Table S2](#SD3){ref-type="supplementary-material"}). The gene signatures of PMPs and mesenchymal progenitors are similar, regardless that PMPs were sampled from E16.5 mouse lung.

Classification of Mesothelial Cells {#S9}
-----------------------------------

Mesothelial cells provide a slippery, non-adhesive, and protective surface that wrap the internal organs and the body's cavities. WT1 lineage mesothelial cells were shown to give rise to desmin^+^CD34^+^ fibroblasts, as well as bronchial and vascular smooth muscle cells ([@R8]; [@R12]). The previously reported markers for mesothelial cells are *Wt1*, *Upk3b*, *Lrrn4*, *Msln*, and *Calb2* ([@R13]; [@R26]; [@R46]; [@R47]). Notably, cells enriched for these common genes are clustered tightly, and we subsequently identified them as the mesothelial cell subtype ([Figures S4A--S4C](#SD1){ref-type="supplementary-material"}). Identification of the subtype distinguished genes revealed *Lgals2*, *Cxcl13*, *Gpm6a*, *Rspo1*, and *Nkain4* as novel putative markers for mesothelial cells ([Figures S4D and S4E](#SD1){ref-type="supplementary-material"}). The top lncRNA for the mesothelial subtype is *Gm12840* ([Figure S4F](#SD1){ref-type="supplementary-material"}). The 50 most significant genes were highly and specifically expressed in mesothelial cells ([Figure S4G](#SD1){ref-type="supplementary-material"}). Zinc finger gene *Bnc1* is the best transcription factor uniquely identified in this cluster ([Figure S4H](#SD1){ref-type="supplementary-material"}). Other highly distinctive transcription factors include *Aebp1*, *Wt1*, *Gata6*, and *pdlim4* ([Figure S4I](#SD1){ref-type="supplementary-material"}).

Discovering the Newly Emerging Pdgfrb High Fibroblasts in Fibrotic Lung {#S10}
-----------------------------------------------------------------------

The comparison of normal and fibrotic MCs led us to uncover a newly emerging MC subtype expressing high levels of *Pdgfrb*. The *Pdgfrb* expressing cells were scattered in the myofibro-blast, matrix fibroblast, mesothelial, and endothelial subtypes in normal MCs; the same pattern was found in fibrotic MCs, but the proportion of *Pdgfrb* expressing cells was increased. When using Pdgfrβ antibody to stain fibrotic lungs, the labeled cells were expanded as compared to normal lungs ([@R4]; [@R63]), which is consistent with our scRNA-seq data ([Figure S5A](#SD1){ref-type="supplementary-material"}). In addition, the *Pdgfrb* highly expressing MCs were clustered together and can be distinguished collectively from the nearby myofibroblast subtype ([Figures 6A and 6B](#F6){ref-type="fig"}). Thus, despite co-expressing genes such as *Acta2* and *Kcnk3*, *Pdgfrb* hi and myofibroblast subtypes were separated and represent distinct clusters. *Pdgfrb* hi fibroblasts expressed perfectly discriminating markers, including *Higd1b*, *Cox4i2*, *Notch3*, *Fam162b*, *Postn*, *Col8a1*, *Lmcd1*, *Tmem178*, *Hbegf*, and *Lipg* ([Figure 6C](#F6){ref-type="fig"}). lncRNAs found in the *Pdgfrb* hi subtype were not remarkable ([Figure 6D](#F6){ref-type="fig"}). *Postn*, *Higd1b*, and *Col8a1* were highly distinctive extracellular expressing genes. Plasma membrane expressing genes other than *Pdgfrb* were *Gucy1b3*, *Tmem178*, *Pcdh18*, and *Sgip1* ([Figure 6E](#F6){ref-type="fig"}). The *Pdgfrb* hi subtype was best delineated by transcription factor *Notch3* ([Figure 6F](#F6){ref-type="fig"}) and Notch downstream effector *Nrarp*. Other transcription factors such as *Ebf1* and *Lef1* were discriminatively expressed in this subtype ([Figure 6G](#F6){ref-type="fig"}). It is interesting that Nrarp also is involved in stabilizing LEF1 in regulating Wnt signaling ([@R24]), suggesting a role of the Notch-Wnt signaling pathways in this *Pdgfrb* hi subtype. Because *Notch3* and *Pdgfrb* have been suggested to be pericyte markers, we checked the other previously suggested pericyte markers in the current scRNA-seq data: *Mcam* (*Cd146*) ([@R4]), labeled *Pdgfrb* hi, endothelial, lipofibroblast subtypes ([Figure S5B](#SD1){ref-type="supplementary-material"}); *Cspg4* (*Ng2*) ([@R4]; [@R22]), labeled few cells scattered in the *Pdgfrb* hi, myofibroblast, matrix fibroblast; and lipofibroblast MC subtypes ([Figure S5C](#SD1){ref-type="supplementary-material"}). These data suggested that *Pdgfrb* hi fibroblasts are newly emerging MCs in response to the fibrotic injury, but there was no distinct pericyte cluster in the analysis. The potential overlaps with pericytes anatomically and functionally remain to be determined.

Uncovering the Transcriptional Program of Endothelial Cells {#S11}
-----------------------------------------------------------

Given the fact that a close relation exists between endothelial cells and fibroblasts ([@R30]; [@R63]), we included endothelial cells in the analysis. We detected a cluster of cells enriched for endothelial cell markers, including *Pecam1*, *Cdh5*, *Edn1*, *Kdr*, *Ets1*, and *Gata2* ([Figures S6A--S6D](#SD1){ref-type="supplementary-material"}). A set of strong, unique signature genes, including *Cldn5*, *Cyyr1*, *Clic5*, *Clec14a*, and *Tspan7*, were found to be highly and specifically expressed in endothelial cells from both normal and fibrotic lungs ([Figures S6E and S6F](#SD1){ref-type="supplementary-material"}). *Bvht* is the top endothelial expressed lncRNA and the prevalence of this lncRNA in endothelial cluster is \~30% ([Figure S6G](#SD1){ref-type="supplementary-material"}). *Bvht* has been shown to have a key role in cardiac differentiation, including vascular endothelium ([@R28]). The top 50 most distinct signature genes in endothelial cells were plotted as a heatmap and analyzed for the differences between normal and fibrotic lungs ([Figure S6H](#SD1){ref-type="supplementary-material"}). The most uniquely discriminative transcription factor is *Sox18*, which is slightly increased in the endothelial cluster in fibrotic lungs ([Figure S6I](#SD1){ref-type="supplementary-material"}). Transcription factors, including *Epas1*, *Klf2*, *Ppp1r16*, *Gata2*, *Sox17*, and *Ahr*, also are significantly expressed in endothelial cells ([Figure S6J](#SD1){ref-type="supplementary-material"}).

Differentiation Potential of the MC Subtypes {#S12}
--------------------------------------------

We used self-organizing maps (SOMs) by single-cell R analysis tool based on SOM machine learning (SCRAT) ([@R7]) to determine and envision coincidental gene sets exhibited in each population of MCs during fibrogenesis formation. The analysis revealed that MC subtypes expressed variable signatures under normal and fibrotic conditions ([Figures 7A and 7B](#F7){ref-type="fig"}). We demonstrated multiple subtype-specific gene signatures, including extracellular region, extracellular space, neutrophil chemotaxis, ribosome, structural constituent of ribosomes, plasma membrane, integral component of membrane, endoplasmic reticulum, endoplasmic reticulum membrane, chromosome 12, signal transducer activity, structural constituent of muscle, ATP hydrolysis-coupled proton transport, regulation of transcription, and DNA-templated nuclear speck ([Figures 7A and 7B](#F7){ref-type="fig"}). Notably, at the fibrotic stage, the myofibroblast subtype acquired a gene signature involving the structural constituent of muscle. *Col13a1* and *Col14a1* matrix fibroblasts as well as lipofibroblasts lost the signature of neutrophil chemotaxis. Mesothelial cells displayed gene signatures similar to *Col14a1* matrix fibroblasts following fibrotic injury.

We then projected MCs onto the SCRAT for sample similarity and pseudo-time analysis, which provides information inferring lineage trajectories from single-cell expression data in the form of 2D bifurcation. We assigned major MC subtypes onto SCRAT, including myofibroblasts, *Col13a1* matrix fibroblasts, *Col14a1* matrix fibroblasts, lipofibroblasts, mesenchymal progenitors, and *Pdgfrb* hi MCs. We found that the correlation-spanning tree and trajectory report displayed a directed hierarchical relation of the various subgroups, starting from mesenchymal progenitors and bifurcated to other MC subtypes ([Figures 7C and 7D](#F7){ref-type="fig"}). It is interesting that our SCRAT analysis demonstrated a different lineage hierarchy among the MC subpopulations between normal and fibrotic stages. In the normal lung, mesenchymal progenitors bifurcated to lipofibroblasts and *Col14a1* matrix fibroblasts, whereas *Col14a1* matrix fibroblasts diverged to myofibroblasts and *Col13a1* matrix fibroblasts. In the fibrotic lung, mesenchymal progenitors branched to lipofibroblasts and then lineage differentiated to the *Pdgfrb* hi subtype, myofibroblasts, *Col14a1* matrix fibroblasts, and *Col13a1* matrix fibroblasts sequentially.

Comparison between the Present Study and Recent Reports of Single-Cell Sequencing of Mesenchymal Cells {#S13}
------------------------------------------------------------------------------------------------------

Recent single-cell studies reported by [@R66] showed that distinct Axin2^+^Pdgfrα ^+^ mesenchymal alveolar niche cell (MANC) and Axin2^+^ mesenchymal progenitor (AMP) subpopulations are found by scRNA-seq. We extracted the significant genes of MANCs and AMPs from the reports of [@R66] and compared the transcriptional programs of these two subgroups with our study ([Figures S7A and S7B](#SD1){ref-type="supplementary-material"}). AMPs, which have higher Acta2 expression levels, show correlation with our myofibroblast subgroup on D0 and *Pdgfrb* hi subgroup on D21. MANCs, which are expanded post-injury and mainly Pdgfrα ^+^, are similar to the Col13a1/Col14a1 matrix fibroblasts. Our analysis revealed two more mesenchymal cell types in the normal lung compared to the [@R66] study. This may be because the cells included in our study are a larger population. Our analysis included all of the Epcam^−^CD31^−^CD45^−^ cells, and Tbx4 lineage cells represent \~90% of the total Epcam^−^ CD31^−^ CD45^−^ cells ([@R63]). All of the Axin2^+^, Axin2^+^Pdgfrα ^+^, Pdgfrα ^+^, and other cells compose \~50% of the Epcam^−^ CD31^−^ CD45^−^ cells, when interpreted from Figures S1H and S1I in [@R66]. Wnt2^+^ cells may constitute only a portion of the rest of the mesenchymal cells because Wnt2^+^ cells have \~85% overlap with Pdgfrα ^+^ cells and \~30% overlap with Axin2^+^ cells. It is unexpected to see that the scRNA-seq analysis segregated Wnt2^+^ cells so well from the other populations when they are supposed to have large overlaps. All of these in turn may lead this previous analysis to reveal limited mesenchymal subgroups.

A recent single-cell study by [@R33] showed that Lgr5 and Lgr6 lineage cells are epithelial niche-promoting MCs located in alveolar and airway compartments, respectively. In our study, most of the Lgr5 and Lgr6 expressing cells are found within Acta2 hi expressing myofibroblasts ([Figure S7C](#SD1){ref-type="supplementary-material"}). In the D0 single-cell analysis, there are 93 Lgr5^+^ cells, 44 Lgr6^+^ cells, 13 Lgr5^+^/Lgr6^+^ cells, and 19 Lgr6^+^/Acta2^+^ cells. By D21, there are 124 Lgr5^+^ cells, 120 Lgr6^+^ cells, 31 Lgr5^+^/Lgr6^+^ cells, and 71 Lgr6^+^/Acta2^+^ cells. Lgr5 and Lgr6 may be the two subclusters of the myofibroblast subgroup with distinct locations. The Lgr5^+^/Lgr6^+^ cells found in our analysis are consistent with the claim by [@R33] that Lgr6 marks cell populations expressing Lgr5.

DISCUSSION {#S14}
==========

In this study, we used unbiased single-cell transcriptome analyses to comprehensively classify the MC subtypes and cell lineage potential of individual MCs in the normal and fibrotic mouse lung. The analyses identified adult pulmonary MCs, including myofibroblasts, *Col13a1* matrix fibroblasts, *Col14a1* matrix fibroblasts, lipofibroblasts, mesenchymal progenitors, and mesothelial cells, as heterogeneous populations. In addition, the *Pdgfrb* hi fibroblast subpopulation was found to emerge in fibrogenesis. Our data provided combinatorial information of the signature genes, lncRNAs, extracellular and plasma membrane genes, and transcription factors for each of the MC subtypes. The fibroblast differentiation potential analyses identified different cell lineage trajectories between normal homeostasis and fibrotic conditions.

Are Myofibroblasts the Major Expanded MCs in Fibrotic Lung? {#S15}
-----------------------------------------------------------

Myofibroblasts express α SMA with features reminiscent of both fibroblasts and smooth muscle cells ([@R20]), and are the vital players in fibrotic diseases ([@R61]). When performing α SMA antibody staining or using α*SMA-GFP*-reporting mice, α SMA^+^ cells are dramatically expanded during fibrogenesis ([@R63]). We observed that *Acta2* highly expressing cells are within the myofibroblast subtype; the low *Acta2*-expressing cells that express *Col1a1* are matrix fibroblast subtypes. The percentage of matrix fibroblasts is \~30% in normal MCs and increases to 50% in the fibrotic MCs. These scRNA-seq analyses suggest that α SMA is not specific enough to discriminate myofibroblasts from matrix fibro-blasts. Therefore, many previously reported data that α SMA-expressing cells expand in lung fibrosis may be in fact mainly the result of matrix fibroblast amplification.

Lipofibroblasts Are Further Delineated under Homeostatic and Fibrotic Conditions {#S16}
--------------------------------------------------------------------------------

Lipofibroblasts contain lipid in the form of large cytoplasmic lipid droplets without a limiting biomembrane or lipid vacuoles ([@R43]; [@R53]). Lipofibroblasts are involved in alveolar development and regeneration associated with alveolar epithelial type II cells (AECII) surfactant synthesis and vitamin A (retinoic acid) storage ([@R53]), and contribute to the AECII stem cell niche in the adult mouse lung ([@R3]). Adipose differentiation-related protein (ADRP, encoded by *Plin2*) is believed to be the major component that mediates the consumption of lipid inclusions in lipofibroblasts and their subsequent transport to AECII cells ([@R17]). Common adipocyte genes, including *Pparg*, *Plin2*, *Fabp1*, *Fabp4*, *Fabp5*, *Lpl*, and *Lipa*, are featured in lipofibroblasts ([@R9], [@R10]; [@R15]; [@R23]; [@R38]; [@R51]; [@R59]). On the basis of these previously suggested lipofibroblast markers, we identified the lipofibroblast subtype in which these markers are substantially highly expressed in our scRNA-seq data. These cells also express common fibroblast markers such as *Vim*, *Col4a1*, and *Fn1*. Concurrently, this subtype may exhibit signature genes related to immune responses. Specifically, an M2-like macrophage gene signature also was found in the subtype. However, lipofibroblasts do not express classical macrophage markers such as *Ccr2*, *Lst1*, *Ms4a6c*, *plac8*, and *Ifitm3*. These M2-like signature genes include *Chil3*, *Mrc1(CD206)*, *IL18*, and *CD9*. A recent study showed that a subset of M2-like macrophages was defined by using scRNA-seq of FACS-sorted 68 CD45^+^, CSF1R^−^ GFP^+^, F4/80^+^, and Ly6G^−^individual cells from mouse lung 7 days post-partial pneumonectomy and was a component of the regenerative AECII niche ([@R32]). The relation between lipofibroblasts and M2-like macrophages warrants further investigation.

Are Lipofibroblasts Pdgfra^+^ Cells? {#S17}
------------------------------------

It is reported that Pdgfrα was expressed in a population of stem cell antigen-1 (Sca1)^+^ and CD34^+^, CD45^−^, CD31^−^, and Thy-1^+^ cells, which also were lipid-staining positive ([@R44]), *Pdgfra*^+^ cells from *Pdgfra*;H2B-GFP mice contained lipid droplets and were supportive of the expansion and differentiation of epithelial cells *in vitro* ([@R3]). A subpopulation of *Pdgfr*α^+^ fibroblasts are α SMA^+^ peribronchiolar smooth muscle and myofibroblasts in alveolar development ([@R10]; [@R16]). By using *Pdgfra*-GFP mice, Pdgfrα expressing precursor cells differentiate into myofibroblasts as well as lipofibroblasts, while the constitutive *Pdgfracre* mice revealed that the Pdgfrα signaling is restricted to bronchial smooth muscle cells and alveolar fibroblasts. Therefore, the overlap and the differences between Pdgfrα ^+^ fibroblasts and lipofibroblasts can be delineated. It is interesting that our scRNA-seq data showed that *Pdgfra*^+^ cells were mainly within *Col13a1* and *Col14a1* matrix fibroblasts. *Pdgfra* expression was low in *Acta2*^+^ myofibroblasts and lipofibroblasts ([Figure S2B](#SD1){ref-type="supplementary-material"}). Some *Pdgfra*^+^ matrix fibroblasts expressed *Adrp*, *Lpl*, and *Lipa*, but not *Pparg* and *Fabp1,4,5*. These results provide new insights into *Pdgfra*^+^ cells and suggest that they are mainly matrix fibro-blasts and can be transdifferentiated from lipofibroblasts.

Are the Newly Emerging Pdgfrb Hi Cells during Fibrogenesis Pericytes? {#S18}
---------------------------------------------------------------------

Our scRNA-seq observations suggested that the *Pdgfrb* hi subtype is a newly emerging MC population in response to the fibrotic injury. Pericytes were reported to be marked by Pdgfrβ protein expression and have established their interactions with endothelial cells ([@R4]). When we used Pdgfrβ antibody to stain fibrotic lungs, the labeled cells were expanded compared to normal lungs ([@R4]; [@R63]). By analyzing the expression of pericyte markers (*Pdgfrb*, *Mcam*, and *Cspg4*), our scRNA-seq data did not indicate a unique cluster for pericytes but suggested a phenomenon that pericytes are heterogeneous and plastic populations ([@R4]) and that they are overlapping with myofibroblasts and matrix fibroblasts. The newly emerging *Pdgfrb* hi MC subtype has uniquely expressed genes that can be cleanly separated from other MCs.

Mesothelial Cells Contribute to Mesenchyme Expansion {#S19}
----------------------------------------------------

Mesothelium contributes to lung mesenchyme during lung development ([@R46]). Wt-1 lineage-traced mesothelium gives rise to interstitial fibroblasts and myofibroblasts, which reside outside the blood vessels and alveoli in the embryonic lung ([@R46]). The contribution of mesothelium to mesenchyme also was detected in disease contexts, including peritoneal, liver, and lung fibrosis ([@R37]; [@R41]; [@R60]). In addition, mesothelial cells can be lineage traced by mesenchymal transcription factor Tbx4 in the lung ([@R30]; [@R63]). Our scRNA-seq data demonstrated well-clustered mesothelial cells in total MCs and in tdT^+^GFP^+^ cells from α*SMA*-GFP;*Tbx4-Cre;Rosa26-tdTomato* mice. Analyses of SOM gene sets revealed that the mesothelial cells displayed gene signatures similar to *Col14a1* matrix fibroblasts in fibrotic lung. Significant gene and transcription factor analyses confirmed previously identified mesothelial markers. Thus, our data confirmed that mesothelial cells contribute to mesenchyme expansion.

Regulation of Fibroblast Subtypes by lncRNAs {#S20}
--------------------------------------------

lncRNAs are emerging as valuable mediators for fibrotic disease ([@R56]; [@R58]). Notably, *Malat1* is highly expressed in the myofibroblast and mesenchymal progenitor subtype. *MALAT1* is one of the top expressed lncRNAs in patients with nonalcoholic steatohepatitis fibrosis. Its expression was increased in activated hepatic stellate cells ([@R35]). *Neat1* is the most abundantly expressed lncRNA in *Col13a1* matrix fibroblasts. It was reported that *Neat1* expression was significantly elevated in mouse liver fibrosis and activated hepatic stellate cells. Suppression of *Neat1* decreased liver fibrosis ([@R65]). Furthermore, *Meg3* is the most distinctly expressed lncRNA in *Col14a1* matrix fibroblasts, and its expression was decreased upon fibrotic injury. It is interesting that *Meg3* has been reported to be the highest expressed lncRNA found in cardiac fibroblasts by global lncRNA profiling, and its inhibition *in vivo* decreased cardiac fibrosis. Silencing of *Meg3* in cardiac fibroblasts decreased cardiac fibrosis ([@R45]). Thus, exploration of these distinguished lncRNAs in different mesenchymal subtypes will provide new insights into fibrogenesis.

Conceptual Exploration of Subgroup Trajectory {#S21}
---------------------------------------------

The trajectory analysis has been used to delineate the cell lineage differentiation in developmental or disease conditions ([@R50]; [@R64]). Pseudo-time analysis implies the state of the lineage initiation subgroup and the potential capacity of transdifferentiation of each subgroup. Cells located on the same or adjacent branches are expected to be more hierarchically related compared to cells on the neighboring branches in a given trajectory tree.

The mesenchymal progenitors are the lineage-initiation MC subgroup in both normal and fibrotic lung. The demonstration that mesenchymal progenitors have the capacity to reconstitute an entire mesenchymal trajectory tree suggested a similarity between the mesenchymal progenitors and previously reported mesenchymal stem cells, although the differences between the two cell types cannot be ignored. Mesenchymal stem cells were reported to be able to differentiate into multiple cell types, including fibroblasts, adipocytes, osteoblasts, chondrocytes, myocytes, and neurons. Our scRNA-seq analysis defined mesenchymal progenitors as resident lung cells. A trajectory analysis found that these progenitors could directly differentiate into lipofibroblasts and *Col14a1* matrix fibroblasts. Our trajectory analysis also suggested that lipofibroblasts are poised for commitment to myofibroblasts through *Pdgfrb* hi subgroup in fibrotic lungs. This prediction is well correlated with a recent report that lipogenic fibroblasts or lipofibroblasts are a source of activated myofibroblasts in lung fibrosis ([@R15]).

Experimental and biological characterizations such as precise lineage tracing and transcriptional conversion of mesenchymal progenitors (and mesenchymal subgroups) and the potential hierarchical differentiation in normal and in disease conditions warrant further investigation. Nevertheless, our trajectory analysis is inconsistent with previous reports and is our attempt to provide a conceptual framework to unmask the hierarchical relations between the mesenchymal subgroups.

In summary, the single-cell transcriptomic analyses dissected heterogeneous MC subtypes in both normal adult and fibrotic mouse lung. These comprehensive analyses provide transcription profiles for delineating mesenchymal taxonomy and add significantly to our understanding of fibroblast subpopulations in lung health and disease by providing a new toolbox to explore effector functions in disease. The study revealed distinctive molecular signatures for mesenchymal subsets in the lung, providing a foundation to augment our understanding of fibro-blast subpopulations and to identify cell markers at the protein level, localization in the lung, signaling programs, and future functional significance. Further identification of ''pathogenic'' fibroblast subpopulations in lung fibrosis will enable us to develop therapeutic targets, as well as more precise cellular and animal models for patients with progressive pulmonary fibrosis.

EXPERIMENTAL PROCEDURES {#S22}
=======================

Mice {#S23}
----

Triple-heterozygous α*SMA*-GFP;*Tbx4-Cre;Rosa26-tdTomato* mice were used. All of the mice were on a C57BL/6 background. The mouse studies were approved by the Institutional Animal Care and Use Committee at Cedars-Sinai Medical Center (protocols IACUC004722 and IACUC004751).

Sequencing Library Construction Using the 10x Genomics Chromium Platform {#S24}
------------------------------------------------------------------------

scRNA-seq libraries were prepared per the Single Cell 3′ Reagent Kit User Guide v2 (10x Genomics). Cellular suspensions were loaded on a Chromium Controller instrument (10x Genomics) to generate single-cell gel bead-in-emulsions (GEMs). GEM-reverse transcriptions (GEM-RTs) were performed in a Veriti 96-well thermal cycler (Thermo Fisher Scientific). After RT, GEMs were harvested and the cDNAs were amplified and cleaned up with the SPRIselect Reagent Kit (Beckman Coulter). Indexed sequencing libraries were constructed using the Chromium Single-Cell 3′ Library Kit (10x Genomics) for enzymatic fragmentation, end-repair, A-tailing, adaptor ligation, ligation cleanup, sample index PCR, and PCR cleanup. The barcoded sequencing libraries were quantified by quantitative PCR using the KAPA Library Quantification Kit (KAPA Biosystems). Sequencing libraries were loaded on a NextSeq500 (Illumina) with a custom sequencing setting (26 bp for read 1 and 98 bp for read 2) to obtain a sequencing depth of \~80,000 reads per cell.

Statistical Method {#S25}
------------------

We used Cell Ranger version 1.3.1 (10x Genomics) to process raw sequencing data and Cell Ranger R kit version 2.0.0 and Seurat suite version 2.0.0 ([@R6]; [@R42]) for downstream analysis. For clustering, principal-component analysis was performed for dimension reduction. Top 10 principal components (PCs) were selected by using a permutation-based test implemented in Seurat and passed to t-SNE for clustering visualization. sSeq version 1.0.0 integrated in the Cell Ranger R kit was used for modeling the gene expression with negative binomial distribution to identify genes whose expression was enriched in specific clusters. The Benjamini-Hochberg procedure was used for correcting errors of multiple testing.

Supplementary Material {#S26}
======================
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![Clustering of Mesenchymal Cells by Single-Cell RNA Sequencing\
(A) Sketch of bleomycin-induced pulmonary fibrosis mouse model.\
(B) Workflow depicts rapid dissociation and sorting of MCs from lung tissue for generating scRNA transcriptome profiles.\
(C and D) 2D visualization of single-cell clustering of MC profiles inferred from RNA-seq data for all MCs in normal (C) and fibrotic (D) α*SMA*-GFP*;Tbx4-Cre;Rosa26-tdTomato* lung samples. Six major classes of MCs in normal lung and seven major classes of MCs in fibrotic lung were detected. Endothelial cells also were included in the analysis. The percentage of each cell population was indicated. Colored bar coded as indicated.\
(E and F) Heat maps of MC normalized signal show MC subtypes changes by top genes (columns) for individual MC subtype cells (rows) in normal (E) and fibrotic\
(F) α*SMA*-GFP*;Tbx4-Cre;Rosa26-tdTomato* lung samples.\
(G and H) Clustering plots depicting single-cell RNA-seq datasets for normal (G) and fibrotic (H) Tbx4-lineage^+^α SMA^+^ MCs acquired from marker-based fluorescence-activated cell sorting (FACS).](nihms957799f1){#F1}

![Transcriptional Profile of Myofibroblasts\
(A and B) Expression patterns of *Acta2* (D0, A; D21, B) in representation as in [Figures 1C and 1D](#F1){ref-type="fig"}.\
(C) Violin plots showing known myofibroblast markers *Acta2*, *Myh11*, and *Tagln* gene expression across all MC clusters.\
(D and E) Representative markers were distinct in normal (D) and fibrotic (E) myofibroblast clusters predicted in the scRNA-seq data.\
(F) Top lncRNAs enriched in myofibroblasts. The size of each circle depicts the percentage of cells in the subtype in which the marker was detected, and its color depicts the average transcript count in expressing cells (nTrans).\
(G) Heatmap of top significant genes, including extracellular and plasma membrane genes in this subtype. Rows correspond to normal (D0) and fibrotic (D21) myofibroblast subtypes, and columns correspond to the mean of the single-cell gene expression signature arranged by expression locations.\
(H) Signature transcription factor *Scx* expression across all MC subtypes.\
(I) Enrichment patterns of transcription factors in the myofibroblast subtype.](nihms957799f2){#F2}

![Matrix Fibroblast Subtype Enriched in *Col13a1*\
(A and B) Visualization of normal (A) and fibrotic (B) *Col13a1* gene expression using a t-SNE plot.\
(C) Expression patterns of known matrix fibroblast marker genes across MC subtypes.\
(D and E) Core distinct expressed genes in *Col13a1* subtype from both normal (D) and fibrotic (E) lungs were indicated by violin plots.\
(F) lncRNAs identified in the *Col13a1* subtype.\
(G) Heatmap of significantly expressed genes with the indication of their cellular locations was compared between normal and fibrotic *Col13a1* subtypes.\
(H) Violin plot of *Tcf21* gene expression, which is highlighted in the *Col13a1* subtype.\
(I) Heatmap showing changes in top transcription factors between normal and fibrotic *Col13a1* subtypes.](nihms957799f3){#F3}

![Characterization of *Col14a1* Matrix Fibroblasts\
(A and B) *Col14a1* expression in normal (A) and fibrotic (B) MC subtypes projected by t-SNE\
(C and D) Enriched signature genes within the normal (C) and fibrotic (D) *Col14a1* MC subtype.\
(E) Subtype significantly expressed lncRNAs.\
(F) Significantly differentiated genes with the indication of cellular location enriched in the *Col14a1* subtype.\
(G) *Prrx1* as the master transcription factor in the *Col14a1* subtype.\
(H) Heatmap showing the highly distinct transcription factors.](nihms957799f4){#F4}

![Molecular Census of Lipofibroblasts\
(A and B) Signature gene *Plin2* expression was visualized in t-SNE plots of normal (A) and fibrotic (B) MCs.\
(C) Violin plots of single-cell expression levels of known lipofibroblast genes across the MC subtypes.\
(D and E) Top unique expressed genes in the normal (D) and fibrotic (E) lipofibroblast subtype.\
(F) Expression patterns of lncRNAs in normal and fibrotic lipofibroblasts.\
(G) Averaged expression of lipofibroblast significant genes in heatmap view. Genes were labeled with the cellular location, as indicated.\
(H) *Nfib* as the most significantly lower expressed transcription factor across the MC subtypes.\
(I) Top transcription factors shown in the lipofibroblast subtype.](nihms957799f5){#F5}

![Newly Emerging Fibrotic MC Subtype Expressing a High Level of Pdgfrb\
(A and B) *Pdgfrb* expression in normal (A) and fibrotic (B) MC subtypes.\
(C--G) Highly unique genes (C), lncRNAs (D), significantly expressed extracellular and plasma membrane expressing genes (E), top transcription factor (F), and enriched transcription factors (G) expressed in fibrotic *Pdgfrb* hi subtype.](nihms957799f6){#F6}

![Metagene Analysis and Differential Potential of MCs\
(A and B) Metagene profile for each MC subtype in normal status (A) and fibrotic status (B). Arrows mark overexpressed and underexpressed metagene signatures. Red shows overexpression and blue shows underexpression.\
(C and D) Lineage bifurcation of five MC subtypes in normal (C) and fibrotic lung (D). Cells on the same or neighboring branches are expected to be more hierarchically related. Color coding indicates pseudo-time scores of the cells.](nihms957799f7){#F7}

###### Highlights

-   Distinct MC subtypes were defined by single-cell transcriptome analysis

-   Lipofibroblasts were identified

-   Fibrotic Pdgfrb high MC subtype emerges post-injury

-   Integrative analysis of MC trajectories was constructed by machine learning
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